NYSE
NHI
Last Price
US $72.95
KEY FIGURES
MKT CAP
$3.5B
EPS
TTM
$3.07
PEG
TTM
-
P/E
TTM
21.18x
P/S
TTM
8.15x
YIELD
5.04%
GROWTH
Revenue Y/Y
2.61%
(FY vs FY)
EBITDA Y/Y
Cash Flow (DCF)
Fair Value
Market $72.95
-62.58%
Default assumptions
EBITDA Multiple
Fair Value
Market $72.95
-76.52%
Default assumptions
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
National Health Investors, Inc. cash flow to debt ratio of 20.64% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
National Health Investors, Inc.'s free cash flow has increased 14.46% from $192.44M last year to $220.26M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
National Health Investors, Inc.'s debt to equity ratio is 0.84, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
National Health Investors, Inc.'s debt has increased relative to shareholder equity from 0.84 last year to 0.84 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
National Health Investors, Inc. has a net debt to EBITDA ratio of 4.06x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial stability - ICR.
National Health Investors, Inc.'s interest coverage ratio of 4.60 indicates that earnings with good margin can cover interest payments on company debt
Financial risk - Profit margin growth.
National Health Investors, Inc.'s profit margin has decreased (-6.55%) in the last year from 41.17% to 38.47%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
National Health Investors, Inc.'s short-term assets of $310.22M exceed its short-term liabilities of $125.00M
Increasing performance - ROA.
National Health Investors, Inc.'s return on assets of 5.63% is higher than the 5.00% threshold, indicating efficient asset utilization
Decreasing performance - Absolute return on equity.
National Health Investors, Inc.'s return on equity of 10.96%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
National Health Investors, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
National Health Investors, Inc. had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
National Health Investors, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
National Health Investors, Inc. has a free cash flow yield of 6.23%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
National Health Investors, Inc.'s yearly earnings has increased 3.04% since last year from $137.99M to $142.18M, signaling increasing performance
Increasing performance - Healthy revenue growth.
National Health Investors, Inc.'s yearly revenue has increased 12.93% since last year from $335.18M to $378.53M, signaling increasing performance
Increasing performance - ROIC.
ROIC 6.91% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
Increasing performance - 3-year revenue CAGR.
National Health Investors, Inc.'s 3-year revenue CAGR of 10.81% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
National Health Investors, Inc. had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
National Health Investors, Inc. had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
National Health Investors, Inc. is overvalued relative to its fair value price of 27.30 based on Discounted Cash Flow model
Undervalued - Earnings yield.
National Health Investors, Inc. has an earnings yield of 4.72%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
National Health Investors, Inc. is overvalued relative to its fair value price of 17.13 based on EBITDA multiple model
Undervalued - EV/EBITDA.
National Health Investors, Inc. has an EV/EBITDA ratio of 16.60x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
National Health Investors, Inc. has a PEG-ratio over 1 which is considered overvalued
Undervalued - P/B ratio.
National Health Investors, Inc. has a price-to-book ratio of 2.23x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Overvalued - P/S ratio.
National Health Investors, Inc. has a price-to-sales ratio of 8.15x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
9.88%
Return on equity
ROIC: 6.91%
Valuation History
24.2X
Price to Earnings
EV/EBITDA: 15.2X
Cash flow
Profit margin
-2.37%
(FY vs FY)
Cash flow Y/Y
-1.03%
(FY vs FY)
Base valuations use default assumptions. Customize in the Valuator.